FDA Approves Implantable Neurostimulator for Epilepsy

Medscape, by Robert Lowes ~ November 14, 2013 The US Food and Drug Administration (FDA) today approved an implantable neurostimulator to reduce the frequency of seizures in patients with epilepsy whose condition is not successfully managed with medication. The device, called the RNS System (Neuropace, Inc), detects abnormal electrical activity and delivers a remedial dose